Market Overview:
The global infant hydrolysate ingredients market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for paediatric food supplements and rising awareness about their benefits among parents. In addition, the growing number of working mothers has led to an increase in demand for ready-to-eat (RTE) infant food products, which are fortified with hydrolysate ingredients. The global infant hydrolysate ingredients market is segmented on the basis of type into general paediatric and paediatric FSMP (foodservice meal replacement). The general paediatric segment is further sub-segmented into powdered and liquid forms. The powdered form dominates the general paediatric segment owing to its ease of use and portability. On the basis of application, the market is divided into 0-6 months, 6-12 months, and above 12 months segments. Among these segments, 0-6 months accounts for a major share owing to early weaning practices followed in various countries across the globe coupled with rising awareness about health benefits associated with early introduction of solid foods into an infant’s diet . Geographically, North America leads this market due high adoption rateof advanced technologies by manufacturers operating in this region as well as presenceof stringent regulatory framework governing product approvals .
Product Definition:
Infant Hydrolysate Ingredients are a group of proteins that have been broken down into small peptides and amino acids. They are used to fortify infant formulas and help with the development of the baby's digestive system.
General Paediatric:
General Paediatrics is the branch of medicine that deals with the study and treatment of children from birth to 18 years of age. The subspecialty involves a wide range of services including clinical procedures, therapeutic interventions, preventive strategies and research in order to improve healthcare delivery for children. According to WHO (2018), there were around 5 billion births globally and approximately 2 million deaths due to under-five child mortality which accounts for about 4% of total deaths worldwide.
Paediatric FSMP:
Paediatric Functional Food and Supplements (FSMP) is a category of food and beverage products that are intended for use by infants, children, teenagers & adults. The product contains nutrients that are required for the normal growth & development of the body as well as aids in preventing diseases. FSMPs have been designed to comply with legal requirements pertaining to nutrition labeling in Europe, Canada and U.S.
Application Insights:
0-6 months application segment led the global infant hydrolysate ingredients market in 2017. The demand for the product is significantly high in this age group as compared to other two application segments as infants require a large amount of calories and nutrients. Infants require around 16-20 calories per ounce while adults require only 10 calories per ounce, thus driving the demand for HHA in 0-6 months age group globally.
The 6-12 months application segment is expected to witness growth at a CAGR of XX% from 2018 to 2030 owing to an increase in product consumption during this period as children progress towards toddlerhood and become more active with increased energy requirements, which drives infant nutrition products such as HHA among other baby food products globally. Furthermore, increasing awareness about healthy eating habits amongst parents will further boost industry growth over the forecast period globally.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to high disposable income of consumers and increasing awareness about infant nutrition among mothers. In addition, new product launches by key companies are anticipated to further boost demand for infant hydrolysate-based products in North America over the forecast period.
Asia Pacific is expected to witness significant growth over the coming years owing to rising disposable income levels and improving standard of living especially in developing countries such as India, China, Indonesia, Malaysia.
Growth Factors:
- Increasing demand for premium and organic infant formula products
- Rising awareness about the benefits of hydrolysate ingredients in infant nutrition
- Growing number of working mothers and their preference for convenient ready-to-feed infant formulas
- Proliferation of new product launches by infant formula manufacturers
- Increasing investments by players in research and development to develop innovative hydrolysate ingredients
Scope Of The Report
Report Attributes
Report Details
Report Title
Infant Hydrolysate Ingredients Market Research Report
By Type
General Paediatric, Paediatric FSMP
By Application
0-6 Months, 6-12 Months, Above 12 Months
By Companies
Nestlé, Danone, Fonterra, Arla Foods Ingredients, FrieslandCampina, Abbott, Mead Johnson & Company, Kerry, Agropur, Hoogwegt, Carbery Group, Ingredia, China Feihe, Tatua, Armor Proteines, Ba'emek Advanced Technologies
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
218
Number of Tables & Figures
153
Customization Available
Yes, the report can be customized as per your need.
Global Infant Hydrolysate Ingredients Market Report Segments:
The global Infant Hydrolysate Ingredients market is segmented on the basis of:
Types
General Paediatric, Paediatric FSMP
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
0-6 Months, 6-12 Months, Above 12 Months
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Nestlé
- Danone
- Fonterra
- Arla Foods Ingredients
- FrieslandCampina
- Abbott
- Mead Johnson & Company
- Kerry
- Agropur
- Hoogwegt
- Carbery Group
- Ingredia
- China Feihe
- Tatua
- Armor Proteines
- Ba'emek Advanced Technologies
Highlights of The Infant Hydrolysate Ingredients Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- General Paediatric
- Paediatric FSMP
- By Application:
- 0-6 Months
- 6-12 Months
- Above 12 Months
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Infant Hydrolysate Ingredients Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Infant hydrolysate is a type of infant formula that is made up of water, milk proteins, and other nutrients. It is designed to help infants who are not getting the recommended amount of protein from their diet. Infant hydrolysate can also be used as a supplement for breastfeeding mothers.
Some of the major players in the infant hydrolysate ingredients market are Nestl©, Danone, Fonterra, Arla Foods Ingredients, FrieslandCampina, Abbott, Mead Johnson & Company, Kerry, Agropur, Hoogwegt, Carbery Group, Ingredia, China Feihe, Tatua, Armor Proteines, Ba'emek Advanced Technologies.
The infant hydrolysate ingredients market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Infant Hydrolysate Ingredients Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Infant Hydrolysate Ingredients Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Infant Hydrolysate Ingredients Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Infant Hydrolysate Ingredients Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Infant Hydrolysate Ingredients Market Size & Forecast, 2020-2028
4.5.1 Infant Hydrolysate Ingredients Market Size and Y-o-Y Growth
4.5.2 Infant Hydrolysate Ingredients Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 General Paediatric
5.2.2 Paediatric FSMP
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 0-6 Months
6.2.2 6-12 Months
6.2.3 Above 12 Months
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Infant Hydrolysate Ingredients Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Infant Hydrolysate Ingredients Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 General Paediatric
9.6.2 Paediatric FSMP
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 0-6 Months
9.10.2 6-12 Months
9.10.3 Above 12 Months
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 General Paediatric
10.6.2 Paediatric FSMP
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 0-6 Months
10.10.2 6-12 Months
10.10.3 Above 12 Months
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 General Paediatric
11.6.2 Paediatric FSMP
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 0-6 Months
11.10.2 6-12 Months
11.10.3 Above 12 Months
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 General Paediatric
12.6.2 Paediatric FSMP
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 0-6 Months
12.10.2 6-12 Months
12.10.3 Above 12 Months
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 General Paediatric
13.6.2 Paediatric FSMP
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 0-6 Months
13.10.2 6-12 Months
13.10.3 Above 12 Months
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Infant Hydrolysate Ingredients Market: Competitive Dashboard
14.2 Global Infant Hydrolysate Ingredients Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Nestlé
14.3.2 Danone
14.3.3 Fonterra
14.3.4 Arla Foods Ingredients
14.3.5 FrieslandCampina
14.3.6 Abbott
14.3.7 Mead Johnson & Company
14.3.8 Kerry
14.3.9 Agropur
14.3.10 Hoogwegt
14.3.11 Carbery Group
14.3.12 Ingredia
14.3.13 China Feihe
14.3.14 Tatua
14.3.15 Armor Proteines
14.3.16 Ba'emek Advanced Technologies
